Vanessa L. Beesley

Vanessa L. Beesley

300 Herston Road
Herston, QLD 4006, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications

Cancer patient distress and health service use is linked with carer distress: evidence from a systematic review and meta-analysis.

Cancer patient distress and health service use is linked with carer distress: evidence from a systematic review and meta-analysis.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: August 29, 2025

Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement.

Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement.

Journal: BMJ open
Published: April 15, 2025

Data sharing in cancer research: A qualitative study exploring community members' preferences.

Data sharing in cancer research: A qualitative study exploring community members' preferences.

Journal: Cancer medicine
Published: May 03, 2024

From many voices, one question: Community co-design of a population-based qualitative cancer research study.

From many voices, one question: Community co-design of a population-based qualitative cancer research study.

Journal: PloS one
Published: April 28, 2024

Psychedelic medicine and cultural responsiveness: A call for Aboriginal and Torres Strait Islander engagement in Australian clinical trials and practice.

Psychedelic medicine and cultural responsiveness: A call for Aboriginal and Torres Strait Islander engagement in Australian clinical trials and practice.

Journal: Australian and New Zealand journal of public health
Published: February 19, 2024

Are exercise and sitting time during chemotherapy for ovarian cancer associated with treatment-related side-effects, chemotherapy completion and survival?

Are exercise and sitting time during chemotherapy for ovarian cancer associated with treatment-related side-effects, chemotherapy completion and survival?

Journal: Gynecologic oncology
Published: February 04, 2024

Pre-post feasibility trial of a telephone-delivered exercise intervention for patients during chemotherapy for recurrent ovarian cancer: the ECHO-R trial protocol.

Pre-post feasibility trial of a telephone-delivered exercise intervention for patients during chemotherapy for recurrent ovarian cancer: the ECHO-R trial protocol.

Journal: BMJ open
Published: January 18, 2024

Impact of disease recurrence on the supportive care needs of patients with ovarian cancer and their caregivers.

Impact of disease recurrence on the supportive care needs of patients with ovarian cancer and their caregivers.

Journal: Gynecologic oncology
Published: November 26, 2023

The Unmet Needs of Pancreatic Cancer Carers Are Associated with Anxiety and Depression in Patients and Carers.

The Unmet Needs of Pancreatic Cancer Carers Are Associated with Anxiety and Depression in Patients and Carers.

Journal: Cancers
Published: September 01, 2023

Exercise during CHemotherapy for Ovarian cancer (ECHO) trial: design and implementation of a randomised controlled trial.

Exercise during CHemotherapy for Ovarian cancer (ECHO) trial: design and implementation of a randomised controlled trial.

Journal: BMJ open
Published: April 13, 2023

Benefits of supportive strategies for carers of people with high-grade glioma: a systematic review : Strategies for addressing the needs of high-grade glioma carers.

Benefits of supportive strategies for carers of people with high-grade glioma: a systematic review : Strategies for addressing the needs of high-grade glioma carers.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: May 16, 2022

Evaluating patient-reported symptoms and late adverse effects following completion of first-line chemotherapy for ovarian cancer using the MOST (Measure of Ovarian Symptoms and Treatment concerns).

Evaluating patient-reported symptoms and late adverse effects following completion of first-line chemotherapy for ovarian cancer using the MOST (Measure of Ovarian Symptoms and Treatment concerns).

Journal: Gynecologic oncology
Published: June 11, 2021
Showing 1-12 of 70

Last Updated: 09/26/2026